Okay, wow, that’s a compound question. So, I’d say, let me just say broadly and then I’ll come back to ACA and other regulatory changes, Marty obviously will have some thoughts on that. But our guidance contemplates all of those issues. Obviously, we just answered a question on payroll services, revenue growth, HRS has remained unchanged. So from that standpoint, we feel comfortable with where we are for the remainder of the year and for the full-year. We don’t focus necessarily on quarters unless there’s some – something unusual in the quarter that we want to call out like Q3, which has one less day. I feel comfortable about where we are in terms of margins and expenses. So that outlook that we’re providing basically encompasses what we understand the environment to be, don’t anticipate it will change significantly. Now, with respect to ACA and with respect to other changes in regulation, it’s a little bit early to call those. The overtime rules change, at this point don’t see a lot of impact on the balance of the year. It could impact next year and then on what exactly happens with ACA, that’s a question to be answered at this point. What I would say is, if we were to see some sort of a significant movement to repeal starting sometime in late Spring, our anticipation of is that were to rollout over a, let’s say, call it a two to three-year period is that we would see about an impact of 1% on EPS per year. If it was more accelerated, it might be more, but we’re still waiting, that that by the way is more of a worse case scenario, 1% to 1.5% EPS. We think we have other options to replace that revenue. But at this point, we would frame sort of the risk if the ACA got repealed in an orderly fashion. If it got replaced and repealed immediately, that would be a different conversation, we’ll have to wait and see where we end up.